Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.0
(0.0%)
CNY 4.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 579.33 Million CNY | -4.56% |
| 2022 | 606.99 Million CNY | -17.61% |
| 2021 | 736.68 Million CNY | -38.75% |
| 2020 | 1.2 Billion CNY | -28.32% |
| 2019 | 1.67 Billion CNY | -22.72% |
| 2018 | 2.17 Billion CNY | -3.98% |
| 2017 | 2.26 Billion CNY | 8.36% |
| 2016 | 2.08 Billion CNY | 13.23% |
| 2015 | 1.84 Billion CNY | 10.77% |
| 2014 | 1.66 Billion CNY | 17.01% |
| 2013 | 1.42 Billion CNY | 41.61% |
| 2012 | 1 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 118.16 Million CNY | -6.66% |
| 2024 Q1 | 145.37 Million CNY | -15.94% |
| 2024 Q2 | 129.56 Million CNY | -10.88% |
| 2023 Q1 | 157.4 Million CNY | -22.17% |
| 2023 FY | 579.33 Million CNY | -4.56% |
| 2023 Q2 | 135.91 Million CNY | -13.65% |
| 2023 Q3 | 113.06 Million CNY | -16.81% |
| 2023 Q4 | 172.94 Million CNY | 52.95% |
| 2022 Q4 | 202.24 Million CNY | 50.47% |
| 2022 FY | 606.99 Million CNY | -17.61% |
| 2022 Q3 | 134.4 Million CNY | -0.44% |
| 2022 Q2 | 134.99 Million CNY | -0.26% |
| 2022 Q1 | 135.35 Million CNY | 0.37% |
| 2021 Q1 | 334.03 Million CNY | 10.37% |
| 2021 Q4 | 134.84 Million CNY | 26.22% |
| 2021 Q2 | 160.97 Million CNY | -51.81% |
| 2021 FY | 736.68 Million CNY | -38.75% |
| 2021 Q3 | 106.83 Million CNY | -33.63% |
| 2020 Q2 | 317.68 Million CNY | 8.77% |
| 2020 FY | 1.2 Billion CNY | -28.32% |
| 2020 Q4 | 302.63 Million CNY | 4.22% |
| 2020 Q3 | 290.36 Million CNY | -8.6% |
| 2020 Q1 | 292.06 Million CNY | -29.05% |
| 2019 Q4 | 411.63 Million CNY | 5.83% |
| 2019 Q3 | 388.96 Million CNY | -3.41% |
| 2019 Q2 | 402.7 Million CNY | -15.17% |
| 2019 Q1 | 474.74 Million CNY | -3.69% |
| 2019 FY | 1.67 Billion CNY | -22.72% |
| 2018 Q2 | 567.55 Million CNY | -8.62% |
| 2018 Q3 | 489.89 Million CNY | -13.68% |
| 2018 Q4 | 492.91 Million CNY | 0.62% |
| 2018 FY | 2.17 Billion CNY | -3.98% |
| 2018 Q1 | 621.07 Million CNY | -4.41% |
| 2017 Q1 | 534.07 Million CNY | -13.38% |
| 2017 FY | 2.26 Billion CNY | 8.36% |
| 2017 Q4 | 649.74 Million CNY | 28.09% |
| 2017 Q3 | 507.26 Million CNY | -11.06% |
| 2017 Q2 | 570.32 Million CNY | 6.79% |
| 2016 Q3 | 471.36 Million CNY | -7.44% |
| 2016 FY | 2.08 Billion CNY | 13.23% |
| 2016 Q4 | 616.6 Million CNY | 30.81% |
| 2016 Q2 | 509.25 Million CNY | 3.99% |
| 2016 Q1 | 489.71 Million CNY | 0.0% |
| 2015 FY | 1.84 Billion CNY | 10.77% |
| 2014 FY | 1.66 Billion CNY | 17.01% |
| 2013 FY | 1.42 Billion CNY | 41.61% |
| 2012 FY | 1 Billion CNY | 0.0% |